Target
Voltage-dependent calcium channel gamma-2 subunit
Ligand
BDBM311816
Substrate
n/a
Meas. Tech.
Calcium Flux Assay
IC50
79.4±n/a nM
Citation
 Ameriks, MKLaforteza, BNLebold, TPRavula, SSavall, BMShireman, BT Fused azaheterocyclic compounds and their use as AMPA receptor modulators US Patent  US10155769 Publication Date 12/18/2018 
Target
Name:
Voltage-dependent calcium channel gamma-2 subunit
Synonyms:
CACNG2 | CCG2_HUMAN | Neuronal voltage-gated calcium channel gamma-2 subunit | TARP gamma-2 | Transmembrane AMPAR regulatory protein gamma-2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
35977.54
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
323
Sequence:
MGLFDRGVQMLLTTVGAFAAFSLMTIAVGTDYWLYSRGVCKTKSVSENETSKKNEEVMTHSGLWRTCCLEGNFKGLCKQIDHFPEDADYEADTAEYFLRAVRASSIFPILSVILLFMGGLCIAASEFYKTRHNIILSAGIFFVSAGLSNIIGIIVYISANAGDPSKSDSKKNSYSYGWSFYFGALSFIIAEMVGVLAVHMFIDRHKQLRATARATDYLQASAITRIPSYRYRYQRRSRSSSRSTEPSHSRDASPVGIKGFNTLPSTEISMYTLSRDPLKAATTPTATYNSDRDNSFLQVHNCIQKENKDSLHSNTANRRTTPV
  
Inhibitor
Name:
BDBM311816
Synonyms:
5-(2-tert-Butyl-7-methyl-imidazo[1,2-a]pyridin-8-yl)-7-methyl-indolin-2-one | US10155769, Example 54
Type:
Small organic molecule
Emp. Form.:
C21H23N3O
Mol. Mass.:
333.4268
SMILES:
Cc1cc(cc2CC(=O)Nc12)-c1c(C)ccn2cc(nc12)C(C)(C)C
Structure:
Search PDB for entries with ligand similarity: